StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Mosaic ImmunoEngineering's free cash flow for the twelve months ending May 31, 2019 was -$760.77K. For fiscal 2019 it was -$760.77K. The highest annual figure on record is -$760.77K in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2019May 31, 2019-$760.77K–
FY2018May 31, 2018-$881.64K–
FY2017May 31, 2017-$1.31M–
FY2016May 31, 2016-$1.58M–
FY2015May 31, 2015-$1.35M–
FY2014May 31, 2014-$1.50M–
FY2013May 31, 2013-$1.01M–
FY2012May 31, 2012-$2.40M–
FY2011May 31, 2011-$4.33M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2019CQ2 2019May 31, 2019-$229.12K–
Q4 FY2018CQ2 2018May 31, 2018-$209.35K–
Q3 FY2018CQ1 2018Feb 28, 2018-$187.89K–
Q2 FY2018CQ4 2017Nov 30, 2017-$255.47K–
Q1 FY2018CQ3 2017Aug 31, 2017-$228.92K–
Q4 FY2017CQ2 2017May 31, 2017-$386.07K–
Q3 FY2017CQ1 2017Feb 28, 2017-$230.99K–
Q2 FY2017CQ4 2016Nov 30, 2016-$274.59K–
Q1 FY2017CQ3 2016Aug 31, 2016-$421.90K–
Q4 FY2016CQ2 2016May 31, 2016-$360.08K–
Q3 FY2016CQ1 2016Feb 29, 2016-$358.97K–
Q2 FY2016CQ4 2015Nov 30, 2015-$307.81K–
Q1 FY2016CQ3 2015Aug 31, 2015-$551.42K–
Q4 FY2015CQ2 2015May 31, 2015-$333.08K–
Q3 FY2015CQ1 2015Feb 28, 2015-$212.55K–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?